01/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/2024

Jan 29, 2024, 14:13 | History
Fabrice Andre: Academic clinical trials should be evaluated mainly based on their IMPACT on patients, not only on innovation
Fabrice Andre, Head of Research Division of Gustave Roussy, President Elect of the European Society…
Jan 29, 2024, 14:00 | Blog
Lisa Lacasse: How we must continue to partner together to reduce disparities
Lisa Lacasse, President of the American Cancer Society Cancer Action Network, shared on LinkedIn: “A…
Jan 29, 2024, 13:54 | Blog
Yousef Zakharia: The Right Person in the Appropriate Position as Editor in Chief for ASCO DailyNews
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post by…
Jan 29, 2024, 13:48 | Blog
Martin Angel: Elegant presentation by Sumanta K. Pal
Martin Angel, Clinical Oncologist at the Institute of Alexander Fleming, shared a post on X/Twitter:…
Jan 29, 2024, 13:41 | Blog
Nina Niu Sanford: Our editorial on radiation omission trials is out in JCO Oncology Practice
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared a…
Jan 29, 2024, 13:37 | Blog
Sarah Sammons: Learning about Leptomeningeal Disease in Breast Cancer
Sarah Sammons, Breast Medical Oncologist at Dana-Farber's Breast Oncology Center, shared a post on X/Twitter:…
Jan 29, 2024, 13:33 | Blog
Richard Sullivan: Superb work by Jordanian colleagues to develop Jordan's National Palliative and Home Care Strategic Framework
Richard Sullivan, Professor of Cancer and Global Health at King’s College London, shared a post…
Jan 29, 2024, 11:02 | Blog
Matthijs Van Meerveld: No test, no treatment
Matthijs Van Meerveld, Associate Vice President of Global Head of Access Policy & Patient Advocacy,…
Jan 29, 2024, 10:53 | Insight
Paolo Tarantino: The highly debated results of PALOMA2 now published on JCO
Paolo Tarantino, Medical Oncologist, PhD Università degli Studi di Milano, Research Dana-Farber Cancer Institute, Harvard…
Jan 29, 2024, 10:40 | Blog
Petros Grivas: Our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting
Petros Grivas, Clinical Director of Genitourinary Cancers Program, UW Medicine, shared on X/Twitter: "Excited for…
All: 710 Posts: 61 - 70